Back to search

Article

The splicing factor U2AF1 contributes to cancer progression through a non-canonical role in translation regulation

2018-07-18

Abstract excerpt

Somatic mutations in the genes encoding components of the spliceosome occur frequently in human neoplasms, including myeloid dysplasias and leukemias and less often in solid tumors. One of the affected factors, U2AF1, is involved in splice site selection, and the most common change, S34F, alters a conserved nucleic acid binding domain, recognition of the 3’-splice site, and alternative splicing of many mRNAs. Howe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
387aeec8-869a-55e6-9917-b3c79ae02f49
DOI
10.1101/371492
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The splicing factor U2AF1 contributes to cancer progression through a non-canonical role in translation regulationDOI 10.1101/371492
Select a neighboring publication to make it the new centre.